Vasopressin in hemorrhagic shock: Review article

American Surgeon

Volumn 75, Issue 12, 2009, Pages 1207-1212

  Rajani, Ravi R ^a   Ball, Chad G ^a   Feliciano, David V ^a   Vercruysse, Gary A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 DESAMINO 8 DEXTRO ARGININE VASOPRESSIN; ADRENALIN; CATECHOLAMINE; NORADRENALIN; PHENYLEPHRINE; UNCLASSIFIED DRUG; VASOPRESSIN;

CLINICAL TRIAL; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; HEMORRHAGIC SHOCK; HUMAN; NONHUMAN; RESUSCITATION; REVIEW; SEPTIC SHOCK; TREATMENT OUTCOME;

ANIMALS; HEMOSTATICS; HUMANS; RECEPTORS, VASOPRESSIN; SHOCK, HEMORRHAGIC; SHOCK, SEPTIC; VASOPRESSINS;

EID: 73449102190     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Jocheberger S, Mayr VD, Luckner G, et al. Serum vasopressin concentrations in critically ill patients. Crit Care Med 2006; 34:293-9.
2. Committee on Injury Prevention and Control, Institute of Medicine. Bonne RJ, Fulco CE, Liverman CT, eds. Reducing the Burden of Injury: Advancing Prevention and Treatment. Washington DC: National Academy Press; 1999.
3. Oliver GS, Schafer EA. On the physiological action of extracts of pituitary body and certain other glandular organs. J Physiol 1895;18:277-9.
4. Velden RVD. Die nierenwirkung von hypophysenextrakten beim menschen. Berl Klin Wochenschr. 1913;50:2083-6.
5. Du Vigneaud V, Gash DT, Katsoyannis PG. A synthetic preparation possessing biological properties associated with arginine-vasopressin. J Am Chem Soc 1954;76:4751-2.
6. Kehne S, Hughes FA, Gompertz ML. The use of surgical pituitrin in the control of esophageal varix bleeding. Surgery 1956; 39:917-25.
7. Webster W. The Science and Art of Anesthesia. St. Louis: Mosby. 1924.
8. Swaab DF, Nijveldt F, Pool CW. Distribution of oxytocin and vasopressin in the rat supraoptic and paraventricular nucleus. J Endocrinol 1975;67:461-2.
9. Kovacs L, Robertson GL. Syndrome of inappropriate anti-diuresis. Endocrinol Metab Clin North Am 1992;21:859-75.
10. Schrier RW, Berl T, Anderson RJ. Osmotic and nonosmotic control of vasopressin release. Am J Physiol 1979;236:F321-32.
11. Wood CE, Chen HG. Acidemia stimulates ACTH, vasopressin, and heart rate responses in fetal sheep. Am J Physiol 1989; 257:R344-9.
12. Holmes CL, Patel BM, Russell JA, et al. Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120:989-1002.
13. Errington ML, Rocha e Silva M. The secretion and clearance of vasopressin during the development of irreversible hemorrhagic shock. J Physiol 1971;217:43-5.
14. Baumann G, Dingman J. Distribution, blood transport, and degradation of antidiuretic hormone in man. J Clin Invest 1976;57: 1109-16.
15. Mutlu GM, Factor P. Role of vasopressin in the management of septic shock. Intensive Care Med 2004;30:1276-91.
16. Holmes CL, Landry DW, Granton JT. Science review: vasopressin and the cardiovascular system. Crit Care 2003;7: 427-34.
17. Thibonnier M. Signal transduction of V1-vascular vasopressin receptors. Regul Pept 1992;38:1-11.
18. Laszlo FA, Laszlo F, DeWied D. Pharmacology and clinical perspectives of vasopressin antagonists. Pharmacol Rev 1991;43: 73-108.
19. Vanhoutte PM, Katusic ZS, Shepherd JT. Vasopressin induces endothelium-dependent relaxations of cerebral and coronary, but not of systemic arteries. J Hypertens Suppl 1984;2: S421-2.
20. Oyama H, Suzuki Y, Satoh S, et al. Role of nitric oxide in the cerebral vasodilatory responses to vasopressin and oxytocin in dogs. J Cereb Blood Flow Metab 1993;13:285-90.
21. Luk J, Ajaelo I, Wong V, et al. Role of V1 receptors in the action of vasopressin on the baroreflex control of heart rate. Am J Physiol 1993;265:524-9.
22. Cowley AW, Monos E, Guyton AC. Interaction of vasopressin and the baroreceptor reflex system in the regulation of arterial blood pressure in the dog. Circ Res 1974;34:505-14.
23. Noguera I, Medina P, Segarra G, et al. Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery. Br J Pharmacol 1997;122:431-8.
24. Segarra G, Medina P, Domenech C, et al. Role of vasopressin on adrenergic neurotransmission in human penile blood vessels. J Pharmacol Exp Ther 1998;286:1315-20.
25. Dw L, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001;345:588-95.
26. Sharshar T, Carlier R, Blanchard A, et al. Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med 2002;30:497-500.
27. Giusti-Paiva A, De Castro M, Antunes-Rodrigues J, Carnio EC. Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release during experimental septic shock. Crit Care Med 2002;30:1306-10.
28. Garrard CS, Kontoyannis DA, Piepoli M. Spectral analysis of heart rate variability in the sepsis syndrome. Clin Auton Res 1993;3:5-13.
29. Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73.
30. Mark P, Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994;272:1354-7.
31. Levy B, Bollaert P, Charpentier C, et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 1997; 23:282-7.
32. Sharma RM, Setlur R. Vasopressin in hemorrhagic shock. Anesth Analg 2005;101:853-4.
33. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997;95:1122-5.
34. Landry DW, Levin HR, Gallant EM, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997;25:1279-82.
35. Malay MB, Aston RC, Landry DW, Townsend RN. Lowdose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999;47:699-705.
36. Dunser MW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 2003;107:2313-9.
37. Micek ST, Shah P, Hollands JM, et al. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study. Surg Infect (Larchmt) 2007;8:189-99.
38. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-87.
39. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-326.
40. Dries DJ. Hypotensive resuscitation. Shock 1996;6:311-6.
41. Bickell WH, Wall MJ Jr, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994;331:1105-9.
42. Roberts I, Evans P, Bunn F, et al. Is the normalization of blood pressure in bleeding trauma patients harmful? Lancet 2001; 357:385-7.
43. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63:805-13.
44. Martinowitz U, Kenet G, Segal E, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001;51:431-9.
45. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008; 248:447-58.
46. Balogh Z, McKinley BA, Holcomb JB, et al. Both primary and secondary abdominal compartment syndrome can be predicted early and are harbingers of multiple organ failure. J Trauma 2003; 54:848-61.
47. Voelckel WG, Lurie KG, Lindner KH, et al. Vasopressin improves survival after cardiac arrest in hypovolemic shock. Anesth Analg 2000;91:627-34.
48. Haas T, Voelckel WG, Wiedermann F, et al. Successful resuscitation of a traumatic cardiac arrest victim in hemorrhagic shock with vasopressin: a case report and brief review of the literature. J Trauma 2002;57:177-9.
49. Tsuneyoshi I, Onomoto M, Yonetani A, et al. Low-dose vasopressin infusion in patients with severe vasodilatory hypotension after prolonged hemorrhage during general anesthesia. J Anesth 2005;19:170-3.
50. Morales D, Madigan J, Cullinane S, et al. Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 1999;100:226-9.
51. Raedler C, Voelckel WG, Wenzel V, et al. Treatment of uncontrolled hemorrhagic shock after liver trauma: fatal effects of fluid resuscitation versus improved outcome after vasopressin. Anesth Analg 2004;98:1759-66.
52. Stadlbauer KH, Horst WG, Raedler C, et al. Vasopressin, but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs. Anesthesiology 2003;98:699-704.
53. Feinstein AJ, Patel MB, Sanui M, et al. Resuscitation with pressors after traumatic brain injury. J Am Coll Surg 2005;201: 536-45.
54. Feinstein AJ, Cohn SM, Sanui M, et al. Early vasopressin improves short term survival after pulmonary contusion. J Trauma 2005;59:876-83.
55. Meybohm P, Cavus E, Bein B, et al. Small volume resuscitation: a randomized controlled trial with either norepinephrine or vasopressin during severe hemorrhage. J Trauma 2007;62: 640-6.